# P12 Mock Review Round 2 — GenAI4Health @ NeurIPS 2026

**Review basis.** I reviewed the rendered 23-page PDF (main paper pp. 1–9), the
current TeX, `SOURCES.md`, generated TeX artifacts, the round-1 review and
numerical audit, and the current `p1b_full_inventory.json`, `p1c_stats.json`,
`p7b_gap_trend.json`, and `p3b_fp32.json`. All comparisons below use stored
prediction dtype as the definition of probe precision, as requested. Reviewers
would see the PDF, so a correction present only in an unused generated table
does not count as a correction to the submission.

## Round-1 repair verification

| Requested repair | Round-2 verdict | Verification |
|---|---|---|
| 1. Withdraw “racial AUC gap widens as models improve” | **Not cleanly fixed** | Section 5.3 and Appendix C now disclaim a harm/equity conclusion, which is directionally correct, but they still print a positive checkpoint trend and incorrectly say it “fails” BH with \(q=0.0232\), which is below 0.05. More seriously, the branch code treats fp32 re-probes of the same RANDOM and INTENSITY encoders as four new branches. The PDF/artifact value is \(n=11,\rho=+0.518,p=0.1025\); consolidating by the seven actual pretraining branches gives **\(n=7,\rho=+0.429,p=0.337\)**. On the exclusion-consistent 19-probe base set, race is \(\rho=+0.5105,p=0.0255,q_{\mathrm{BH7}}=0.0595\), as expected. |
| 2. Correct “did not help early disease” | **Partly fixed** | The Abstract and Section 5.3 correctly say mild functional disease improves most: RANDOM 0.8164 to INTENSITY 0.8301, **+0.0137**, versus +0.0102 moderate and +0.0063 severe. However, the Conclusion (p.9, lines 337–338) says the gains “do not reach the groups or the disease stage that need them most,” directly reversing the correction. |
| 3. Exclude two probes; 21 to 19 | **Exclusion fixed; accounting newly confused** | Current `p7b_gap_trend.json` does remove anatomy-v2 ep75/ep92 and explicitly records both exclusions. The PDF’s **27** matches the current JSON because seven fp32 probe re-runs and COVER ep73 were added to the old 19-row set; it is not a residual 21-row calculation. But these technical re-probes are then counted as additional checkpoint observations and, for RANDOM/INTENSITY, as additional “branches,” so the new 27/11 analysis reintroduces pseudo-replication in another form. |
| 4. Rename `oracle` to `intensity` | **Fixed in the body** | The body consistently uses **INTENSITY**. The only body occurrences of “oracle” are the explicit Method explanation that released filenames use the historical name and that it is neither an oracle nor an upper bound (pp.3–4, lines 127–133). |
| 5. Stop mixing epochs in one table column | **Fixed in the main tables** | Table 1 aligns 50/75/100 by column; Table 2 states and displays ep50 for all five policies; Table 5 is ep100; Table 7 is row-wise epoch matched. I found no repeat of round 1’s epoch-100/epoch-50 mixture in a main comparison table. |
| 6. Make headline contrasts precision matched, except COVER ep75 | **Partly fixed; serious disclosure failure remains** | RANDOM/ENVELOPE/INTENSITY contrasts are fp16 matched. ANATOMY-V2 and COVER ep50 are compared with the fp32 RANDOM re-probe, also matched. But COVER ep75 is fp32 (0.8638576) versus fp16 RANDOM (0.8723022), and its \(-0.008445\) contrast is bold in Table 1 and headlined in the Abstract without a dagger. A prose caveat appears only after the result in Section 5.1. This contradicts Table 1’s caption (“lower block is fp32”) and Section 4’s promise that every cross-precision contrast is marked and excluded from headline claims. `p3b_fp32.json` confirms that RANDOM and INTENSITY ep75 fp32 are the two pending re-probes. |
| 7. Report COVER \(f=0.21\), ep75 honestly | **Number correct; framing and state are not** | Inventory: AUC **0.8638576086** (fp32). `p1c`: COVER–RANDOM **−0.0084445608**, CI **[−0.0145882, −0.0025577]**, \(p=0.0058177\); the PDF rounds all correctly. Section 5.1 states both caveats—one floor only and fp32-versus-fp16—but the Abstract generalizes to “over-constraining … is worse,” and Section 5.1 speculates that it “cap[s] what the encoder can still learn.” The setup and limitations also still say COVER halted at ep73 and has no ep75 probe, contradicting Table 1 and Section 5.1. |
| 8. Bound probe-seed variance without calling it pretraining variance | **Fixed** | Discussion p.9, lines 306–315 gives SD 0.0003/0.0018 over five probe seeds, calls them **technical replicates**, and explicitly says they do **not** estimate pretraining noise. `EVIDENCE.md` points to the five-seed experiment. The \(n=1\) continuation limitation is also disclosed in the Abstract, before Results (p.5, lines 184–188), and in Discussion; its placement is now adequate, although several top-level claims remain too categorical. |
| 9. Add occlusion appendix and identify OD/OS storage artifact without overclaiming | **Appendix added; conclusion overclaimed** | Appendix E clearly separates fine-tuned-probe attribution from the frozen-arm comparison and appropriately warns against an anatomical reading of a bimodal population curve. But no actual eye-laterality label is used: the cluster is called “pseudo-laterality,” then asserted to be OD/OS storage and a “direct signature.” Mirrored clusters exclude the proposed bilateral-rim story but do not uniquely identify OD/OS rather than another orientation/acquisition mixture. Calling occlusion “causal” and saying errors reflect saturation “not” wrong structures are also stronger than these perturbation data support. |

---

# Reviewer 1 — Statistics and methodology

## Summary (3 sentences)

The paper compares six OCT I-JEPA masking definitions from a shared epoch-25 fork and uses paired subject-level inference for fixed score vectors. The main fp16 trajectory and the ep50 fp32 controls are numerically reproducible, epoch matched, and much more transparently scoped as single-run observations than in round 1. However, the repaired subgroup analysis has a branch-identity bug, the new highlighted COVER result crosses precision despite a contrary table caption, and adaptive reuse of the test set makes the “pre-specified” inferential language untenable.

## Score and recommendation

- **Score:** **4/10**
- **Recommendation:** **Reject**
- **Confidence:** **5/5**

## Strengths

1. **The fixed-model inference is sound and reproducible (Sections 4 and 5.1; Table 7).** The same 3,000 subjects and label order support correlated DeLong tests and paired, class-stratified bootstrap intervals. The current nine-test BH family is now exactly the nine fp16 RANDOM/ENVELOPE/INTENSITY contrasts; `p1c_stats.json` records family size 9, fixing round 1’s 9-versus-13 discrepancy.

2. **Epoch matching is genuinely repaired (Tables 1, 2, 5, and 7).** Table 1’s columns contain only their named epochs, and the geometry comparison uses ep50 throughout. This is a substantive repair rather than a prose hedge.

3. **Most precision matching is now real (Section 4; Table 1).** Stored dtypes verify fp16 for the three long-horizon arms. At ep50, ANATOMY-V2 0.8653855 and COVER 0.8642814 are compared with the fp32 RANDOM re-probe 0.8641213, yielding the printed +0.0013 and +0.0002.

4. **The single-run limitation is stated early and correctly (Abstract; p.5, lines 184–188; p.9, lines 306–315).** The paper explicitly distinguishes test-subject sampling error from pretraining-run variation and correctly identifies five probe-seed runs as technical replicates only. This addresses the placement problem from round 1.

5. **The new COVER point estimate is accurately transcribed (Section 5.1).** The PDF’s 0.8639, −0.0084, interval, and \(p=0.0058\) agree with `p1b`/`p1c` to rounding, and the paper admits there is only one \(f\) value.

## Weaknesses

1. **[MAJOR] The racial-trend “repair” contains two statistical errors (Section 5.3; Appendix C, Table 4).** First, \(q=0.0232\) does not fail BH at 0.05. Second, `branch_of()` fails to map `frozen_meanpool_random_ep{50,100}_fp32` and `frozen_meanpool_oracle_ep{50,100}_fp32` back to RANDOM and INTENSITY; the PDF therefore reports 11 “branches” even though these are re-probes of existing encoders. The paper/artifact gives \(\rho=+0.518,p=0.1025\); correct seven-branch consolidation gives **\(\rho=+0.429,p=0.337\)**. The 19-row base analysis gives \(q=0.0595\), not the printed 0.0232 produced after adding near-duplicate precision re-probes.
   - **Concrete fix:** map branch identity from the encoder checkpoint hash/arm, not directory strings; treat fp16/fp32 scoring of one encoder as technical measurement repeats, not new checkpoints or branches; regenerate Table 4 and Figure 5. Either present the clean 19-row audit or clearly separate new unique encoder checkpoints from dtype re-probes.

2. **[MAJOR] The COVER ep75 contrast violates the paper’s own precision rule (Abstract; Table 1 caption; Section 4, lines 175–182; Section 5.1, lines 211–220).** COVER is fp32 and RANDOM is fp16, exactly as `p1b` and `\DCoverRandomEpSeventyFiveNullPrec` show. Yet Table 1 says its lower block is fp32 matched, shows no dagger at ep75, and the Abstract makes it a headline; only later prose discloses the crossing. `p3b_fp32.json` has no fp32 RANDOM or INTENSITY ep75 result yet.
   - **Concrete fix:** finish the two pending ep75 fp32 re-probes and regenerate the contrast. If they are unavailable, put a dagger on the ep75 AUC and delta, correct the caption, state “cross-precision exploratory contrast” in the Abstract, and remove causal/mechanistic language.

3. **[MAJOR] “Pre-specified” and confirmatory-looking \(p/q\) values conflict with admitted adaptive test reuse (Abstract; Table 7; Discussion p.9, lines 323–326).** The paper says policies, checkpoints, and analyses were chosen after repeated inspection of this same test split. A nine-row family chosen before running the latest script is not a pre-specified confirmatory family if the broader research program adapted to the test outcomes.
   - **Concrete fix:** delete “pre-specified,” call all current intervals/tests descriptive, and reserve confirmation for a locked external cohort or untouched holdout. If genuine pre-specification exists, cite the timestamped protocol and distinguish it from post-hoc analyses.

4. **[MAJOR] H2 and the title remain stronger than the estimand despite useful new matched data (Sections 3.3, 5.1, and 6).** H2 is ANATOMY \(>\) ENVELOPE, but the prose primarily argues from non-significance versus RANDOM. The direct fully fp32 contrasts already in `p1c` are more informative: ANATOMY-V2–ENVELOPE at ep50 is **−0.010678**, CI **[−0.016778, −0.004547]**, \(p=0.00055\); COVER–ENVELOPE is **−0.011782**, CI **[−0.017016, −0.006674]**, \(p=7.89\times10^{-6}\). These are still one continuation per arm and confounded by mask ratio/context/loss slots, so they establish an observed non-monotone ordering, not that “shape” or “precision” is causally ineffective.
   - **Concrete fix:** report the direct H2 contrasts, change “H2 fails” to “H2 is contradicted in these single continuations,” and retitle/conclude around non-monotonicity. Replicate paired continuations for a policy-level claim; absent that, keep every top-level verb explicitly observational.

5. **[MINOR] “Uncorrelated” overstates an \(n=4\) descriptive coefficient (Abstract; Section 5.2).** A sample Spearman value of exactly 0.00 across four rectangle policies is not evidence of a population null, and the most anatomically pure arm is omitted from that correlation because it is budget-confounded.
   - **Concrete fix:** write “did not order the four observed rectangle-arm AUCs” and avoid a general correlation claim.

## One unsupported claim

> “this fails Benjamini–Hochberg correction over the seven attributes tested (\(q=0.0232\))” (Section 5.3, p.8, lines 266–268)

At the stated 0.05 threshold, 0.0232 passes. The value itself is also driven by treating precision re-probes of shared encoders as extra checkpoint observations; the exclusion-consistent 19-probe result is \(q=0.0595\).

---

# Reviewer 2 — Clinical and health-AI relevance

## Summary (3 sentences)

The study asks a clinically relevant engineering question: whether OCT pretraining needs a segmentation model or can use a cheap image-derived location prior. Round 2 correctly reports that mild functional glaucoma gains the most in the observed epoch-100 comparison and avoids equating a wider max–min race gap with harm. Nevertheless, contradictory conclusion language, invalid branch accounting, absent paired subgroup-change uncertainty, and an AUC-only audit prevent the equity and early-disease material from supporting a trustworthy-health claim.

## Score and recommendation

- **Score:** **5/10**
- **Recommendation:** **Weak Reject**
- **Confidence:** **4/5**

## Strengths

1. **The clinical framing is useful and appropriately bounded (Introduction; Discussion).** Comparing a first-order intensity centroid with MIRAGE-guided masking could matter for implementation cost, segmentation domain shift, and robustness. The paper now explicitly limits conclusions to one FairVision glaucoma task and says the models are not clinically validated.

2. **The severity correction is numerically and clinically clearer (Abstract; Section 5.3; Appendix C, Table 5).** Mild functional disease rises from 0.8164 to 0.8301 (+0.0137), more than moderate (+0.0102) or severe (+0.0063). The paper also correctly distinguishes persistent difficulty ordering from lack of absolute improvement.

3. **The race interpretation is much better than in round 1 (Section 5.3).** The manuscript reports Black AUC increasing from 0.8325 to 0.8472 (+0.0147), notes that all displayed racial strata improve, and explicitly says a widening max–min gap is not evidence of harm.

4. **Subgroup limitations are unusually candid (Appendix C; Broader Impact).** The paper admits shared cases/lineages, one probe seed, repeated test use, no intersectional analysis, and no calibration or fixed-specificity metrics.

5. **“Oracle” is no longer clinically misleading (Method, pp.3–4).** INTENSITY is accurately described as input-derived, annotation-free, and not an upper bound.

## Weaknesses

1. **[MAJOR] The Conclusion reinstates the rejected early-disease claim (Conclusion p.9, lines 337–338).** It says the gains “do not reach the groups or the disease stage that need them most,” whereas the Abstract, Section 5.3, and Table 5 show that mild disease has the largest point gain (+0.0137). This is exactly the kind of no-rebuttal contradiction a reviewer will quote.
   - **Concrete fix:** replace the sentence with: “All displayed groups and severity strata improve in point estimate, mild functional disease most of all, but the worst-served ordering persists and uncertainty on differential benefit remains.” Use “mild functional disease,” not “early disease.”

2. **[MAJOR] “Every group improves; no gap reliably moves” is not supported by the reported uncertainty (Section 5.3).** Absolute subgroup point estimates are shown, but there are no paired CIs for Black/White/Asian changes, severity-stratum changes, or policy-induced changes in max–min gaps. Checkpoint/branch Spearman trends answer a different question and are themselves misgrouped.
   - **Concrete fix:** bootstrap paired within-subgroup arm deltas and the difference in each disparity metric at matched epoch 100. Until then, say “every displayed subgroup point estimate improves” and do not use “reliably.”

3. **[MAJOR] The subgroup trend still uses technical measurements as biological/model replicates (Section 5.3; Appendix C).** Re-scoring the same RANDOM or INTENSITY encoder at fp16 and fp32 does not create a new model trajectory. Counting these in the 27 checkpoint scatter and as four additional branches makes the apparent evidence depend on evaluation dtype duplication, not independent clinical populations or pretraining runs.
   - **Concrete fix:** one row per unique encoder checkpoint for checkpoint plots and one aggregate per true pretraining branch for branch plots. Keep precision robustness in Appendix I, outside the fairness sample size.

4. **[MAJOR] The fairness analysis remains too AUC-centric for a health-AI contribution (Appendix C, lines 587–594).** The authors acknowledge this, but the paper still devotes a headline Abstract contribution to the audit. AUC does not establish calibration, sensitivity at a clinically meaningful specificity, threshold transfer, or equalized performance, and the max–min group can change identity.
   - **Concrete fix:** either demote subgroup auditing entirely to an exploratory appendix or add validation-selected fixed-specificity sensitivity, calibration, and paired disparity-change intervals. Do not call persistence of ordering evidence that a policy did not “introduce” disparity.

5. **[MAJOR] The paper makes a clinical-mechanistic attribution from insufficient occlusion evidence (Appendix E).** Mirrored attribution clusters are consistent with left/right-eye orientation, but the analysis never validates clusters against an OD/OS label. Likewise, diffuse sensitivity in three fine-tuned probes does not show that precise anatomy is unnecessary for glaucoma classification generally or for the frozen representations being compared.
   - **Concrete fix:** validate cluster identity against actual laterality and acquisition-orientation metadata, report a contingency table and uncertainty, and phrase all downstream implications as hypotheses. If laterality is unavailable, use “orientation/storage mixture consistent with OD/OS.”

6. **[MINOR] Cross-sectional mean-deviation strata are not synonymous with early disease (Section 5.3; Appendix C).** “Mild functional loss” does not encode disease duration, conversion risk, or longitudinal onset.
   - **Concrete fix:** replace “early disease” with “mild functional disease by visual-field mean deviation” everywhere, including headings.

7. **[MINOR] Important clinical confounding remains unexamined (Section 5.3).** Race/subgroup AUCs may reflect site, scanner, scan quality, age, or severity composition, and MIRAGE segmentation quality itself may vary by subgroup.
   - **Concrete fix:** add a compact cohort/site/device table and, if metadata permit, stratified or adjusted sensitivity analyses; otherwise name these exact possible mediators.

## One unsupported claim

> “a subgroup audit over 27 probes shows the gains do not reach the groups or the disease stage that need them most” (Conclusion, p.9, lines 337–338)

The paper’s own Table 5 shows gains in all three stages and the largest point gain for mild disease (+0.0137). Section 5.3 also reports a +0.0147 Black AUC gain.

---

# Reviewer 3 — Novelty, positioning, and presentation

## Summary (3 sentences)

The paper is now more honestly positioned as an OCT-specific controlled measurement rather than a general overthrow of informed masking, and the INTENSITY rename materially improves readability. Its visual policy ladder, shared fork, and negative segmentation result could make a useful workshop case study. Yet the rendered artifact is still internally inconsistent, the new COVER result contradicts the stated run history, and the attribution appendix turns a valuable caution into an unverified laterality claim.

## Score and recommendation

- **Score:** **4/10**
- **Recommendation:** **Reject**
- **Confidence:** **5/5**

## Strengths

1. **Positioning is substantially improved (Related Work, pp.2–3; Appendix G).** The paper explicitly says the direction is not new, discusses AutoMAE’s selection dilemma and prior negative informed-masking ablations, and narrows novelty to a shared-fork OCT comparison involving a trained medical segmenter.

2. **The arm nomenclature is now reviewer-safe (Method, pp.3–4).** INTENSITY is descriptive, and the historical `oracle` label is explained exactly once without leaking into body claims.

3. **The core figures and main epoch table are more legible and honest (Figures 1–3; Tables 1–2).** Epochs are aligned, excluded anatomy checkpoints are not used in main contrasts, and Figure 3 labels its small-arm geometry relation descriptive.

4. **The paper foregrounds important negative controls and confounds (Sections 5.2 and 6).** It openly reports differences in mask ratio, retained context, and loss slots and declines to attribute the anatomy result solely to shape.

5. **The attribution appendix begins from a commendable caution (Appendix E).** Calling attention to a plausible-looking bimodal plot that may be generated by scan orientation is useful for a health-imaging audience.

## Weaknesses

1. **[FATAL] The PDF is still not a coherent frozen evidence artifact (Contributions; Appendix A; Appendix I; Reproducibility).** The Contributions say “21 frozen probes,” Section 5.3 says 27, current `p1c_stats.json` contains 28 valid primary frozen-probe rows, and Appendix A’s table titled “All frozen probes” is the stale 21-row version containing two excluded anatomy rows while omitting COVER ep73/75 and all seven completed fp32 re-probes. It labels the original RANDOM/INTENSITY/ENVELOPE predictions `fp32` under an undefined “target precision” column even though their stored `probs` dtypes are fp16, and its caption says “Protocol identical throughout” despite Section 4 explicitly denying a single precision protocol. `SOURCES.md` claims Appendix A uses generated `auto/table_allprobes.tex`, but the TeX instead hard-codes the stale table; Appendix I promises numbers but renders only a red “fp32 re-probe table pending” placeholder even though seven rows exist.
   - **Concrete fix:** make `auto/table_allprobes.tex` and `auto/table_fp32.tex` the actual TeX inputs, rename the column “probe/evaluation dtype,” distinguish valid/excluded/retracted rows, and define why subgroup \(n=27\) differs from current valid-inventory \(n=28\) (COVER ep75 has not entered the subgroup artifact). Rebuild once, extract PDF text, and assert every arm/epoch/precision/count against JSON before submission.

2. **[MAJOR] The COVER chronology contradicts itself (Table 1; Section 4, lines 160–165; Section 5.1; Discussion, lines 316–323).** The paper reports and interprets a probe at ep75, but setup says COVER “was deliberately halted at epoch 73,” and limitations say it has probes “only at epochs 27, 30, 34, 50 and 73” with later probes pending. `p1b` contains the ep75 result, so the prose is stale.
   - **Concrete fix:** state the actual checkpoint history and valid probes consistently in setup, Results, limitations, `SOURCES.md`, and Appendix A. Do not describe ep75 as both observed and pending.

3. **[MAJOR] The new COVER result is visually presented as matched when it is not (Abstract; Table 1).** The row has no precision dagger at ep75, the caption says the lower block uses an fp32 null, and the delta is bold; in fact the comparator is fp16. A later caveat does not repair the false table-level message.
   - **Concrete fix:** use a cell-specific dagger and caption, or wait for the fp32 comparator. Restrict the Abstract to the observed cross-precision association and the single \(f=0.21\) run.

4. **[MAJOR] Appendix E overstates what its attractive figures identify.** “Architecture-agnostic” is fair, but zeroing internal tokens is an off-manifold intervention and does not make attribution generally “causal.” Mirror clustering without ground-truth laterality cannot establish OD/OS as a “direct signature,” and similarly shaped error curves cannot rule out attention to wrong structures. The appendix further jumps from fine-tuned-probe sensitivity to what the frozen pretraining task “does not appear to need.”
   - **Concrete fix:** replace “causal/direct signature/reject” with “model-output sensitivity/consistent with/disfavors,” validate actual laterality if possible, and separate fine-tuned-probe observations from the masking-arm mechanism.

5. **[MAJOR] The title and section headings remain mechanistic while the paper disclaims mechanism (title; “H3: it is not anatomical targeting”; Discussion).** The design varies shape, mask ratio, context, and loss slots together, and the paper explicitly says it cannot identify whether INTENSITY benefits from location consistency, area, or difficulty. “Location, Not Shape” and “it is not anatomical targeting” therefore exceed the design.
   - **Concrete fix:** retitle around the observed non-monotonic ordering, e.g. “An OCT Case Study of Non-Monotonic Performance Across Anatomy-Guided I-JEPA Masking Policies,” and rename H3 as a descriptive geometry audit.

6. **[MINOR] The paper’s reproducibility promise is absolute and immediately falsified by its own appendices (Section 5.5).** Generated files exist, but the manuscript bypasses them for the all-probes and fp32 tables, while `SOURCES.md` is stale about the 21-probe subgroup set and COVER ep75.
   - **Concrete fix:** replace “cannot disagree” with a testable build claim and publish the validation output/hash for the exact PDF.

7. **[MINOR] Double-blind provenance needs a clean public form.** `SOURCES.md` contains a local username and named GitHub/Hugging Face accounts.
   - **Concrete fix:** do not include the internal provenance ledger in the blinded package; provide an anonymized artifact manifest.

## One unsupported claim

> “Every number in this paper is emitted by a single script from those stored predictions, so tables, figures and prose cannot disagree” (Section 5.5, p.8, lines 285–289)

They do disagree: the PDF’s “all probes” table is manually stale, the PDF reports an ep75 COVER result while limitations call ep75 pending, and the subgroup text’s BH/branch statements are numerically wrong.

---

# Meta-review

## Decision

**Reject in its current form.**

The central fixed-score AUC evidence is now substantially more credible: the
round-1 epoch mixture is gone, the six long-horizon contrasts are matched, the
INTENSITY rename is effective, mild-disease point estimates are corrected in
the Abstract/body, and the \(n=1\) limitation is placed early. The rejection is
instead driven by one submission-fatal artifact problem and several major but
repairable analysis/reporting errors: the racial correction is statistically
wrong, the new COVER headline is cross-precision despite a matched-precision
caption, and the PDF’s inventory/provenance/chronology are mutually
inconsistent.

**Unique meta-level count: 1 fatal issue; 8 major issue clusters.**

## Are the round-1 FATAL objections resolved?

**Partial, not complete.**

1. **Single-run policy inference:** the disclosure and placement are now
   adequate, and the paper often says “single-run observation,” so the reporting
   component is substantially repaired. The title, Abstract, H2/H3 headings,
   and Conclusion still use policy-level/mechanistic language, so the objection
   is narrowed rather than eliminated.
2. **Broken/mixed submission artifact:** the main epoch table is genuinely
   fixed, but Appendix A, Appendix I, `SOURCES.md`, probe counts, and COVER
   chronology remain inconsistent. This round-1 fatal is therefore not fully
   resolved.
3. **Fairness/severity overclaim:** the main severity text and absolute race
   interpretation are much better, but the Conclusion reverses the severity
   correction and the racial trend repair contains false BH and branch
   calculations. This is only partially resolved.

## MUST-FIX-BEFORE-SUBMISSION

1. **Freeze one internally consistent PDF.** Use the generated all-probes and
   fp32 tables rather than manual stale versions; reconcile 21/27/28 counts;
   include COVER ep73/75; distinguish probe dtype from pretraining target
   precision; correct the COVER run history; and make `SOURCES.md` describe the
   PDF that is actually built.

2. **Recompute subgroup trends with true pretraining branches.** Collapse fp16
   and fp32 re-probes of the same encoder, map RANDOM/INTENSITY names correctly,
   and report the actual seven-branch race result
   \(\rho=+0.429,p=0.337\). Correct the false statement that \(q=0.0232\) fails
   BH; if using the clean 19-row base set, report \(q=0.0595\).

3. **Resolve or unmistakably flag COVER ep75 precision.** Prefer the pending
   fp32 RANDOM/INTENSITY ep75 re-probes. Otherwise dagger the Table 1 ep75 cells,
   correct the caption, state the cross-precision status in the Abstract, and
   remove “cap/easy signal” and generic “over-constraining is worse” language.

4. **Correct every clinical conclusion.** Remove “gains do not reach” and “does
   not close any gap”; state that all shown subgroup/stage point estimates rise,
   mild functional disease rises most, and differential benefit is uncertain
   without paired subgroup/gap-change intervals.

5. **Align claims with the design.** Report the direct matched-fp32 H2
   contrasts, but describe a non-monotone ordering in single continuations, not
   a causal “location, not shape” result. Keep the early \(n=1\) caveat and make
   the title/Abstract/Conclusion obey it.

6. **Remove unsupported confirmatory language.** The test set was repeatedly
   inspected, so delete “pre-specified” unless a timestamped protocol exists
   and label current \(p/q\) values descriptive.

7. **Repair Appendix E’s attribution claims.** Validate clusters against actual
   OD/OS/orientation metadata or say only that they are consistent with an
   orientation-storage artifact; soften “causal,” “direct signature,” and the
   exclusionary error/mechanism claims.

## NICE-TO-HAVE

1. Add paired CIs for race-stratum, severity-stratum, and disparity changes at
   matched epoch 100.
2. Report calibration and sensitivity at a validation-selected clinical
   specificity, or demote the equity analysis to a compact exploratory appendix.
3. Run paired continuation seeds; absent these, retain the explicitly
   observational case-study framing.
4. Add a budget-matched randomized-band versus intensity-band mechanism arm.
5. Validate on an external OCT cohort and a dense retinal downstream task.
6. Replace “early disease” with “mild functional disease by mean deviation.”
7. Provide an anonymized, versioned artifact manifest and exact submitted-PDF
   hash.

## Estimated acceptance probability

**34%.**

This is materially higher than round 1 because the central AUCs are verified,
the main epoch table is repaired, most precision matching is real, and the
single-run scope is now visible before Results. It remains below even odds
because a no-rebuttal reviewer can directly verify a false BH statement, a
wrong 11-branch analysis, an unmarked cross-precision headline, a stale “all
probes” table, and a Conclusion that contradicts the corrected severity result.
The mostly editorial/recomputation fixes above could move the paper toward
borderline acceptance without another GPU experiment; genuine continuation
replication or external validation would be needed for a confident accept.
